DWIGHT MACERO: Open Payments
NPI 1215312046 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,208 in 8 payments from 6 companies in 2025. Trend: 2023 $1,246 · 2024 $1,565 · 2025 $3,208
Consulting: $2,550Food & beverage: $603Travel & lodging: $55
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $2,774 |
| Syndax Pharmaceuticals, Inc. | 1 | $129 |
| Janssen Biotech, Inc. | 1 | $122 |
| Kite Pharma, Inc. | 1 | $86 |
| Legend Biotech USA Inc. | 1 | $68 |
| Autolus Inc | 1 | $29 |
Products named: REVUFORJ, RYBREVANT, Yescarta, CARVYKTI.
Industry payments across WA — which companies pay providers there.
